SIOX Projected Dividend Yield
Sio Gene Therapies Inc ( OTCBB : SIOX )Sio Gene Therapies is a a clinical-stage company focused on developing gene therapies for neurodegenerative diseases. Co. has three clinical-stage programs: AXO-AAV-GM1 for the treatment of GM1 gangliosidosis; AXO-AAV-GM2 for the treatment of GM2 gangliosidosis (including Tay-Sachs and Sandhoff diseases); and AXO-Lenti-PD for the treatment of Parkinson's disease. 20 YEAR PERFORMANCE RESULTS |
SIOX Dividend History Detail SIOX Dividend News SIOX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |